Metformin radiosensitizes OSCC in 2D and 3D models: possible involvement of CAF-1
Metformin emerged as a promising adjuvant drug in OSCC because of its effects on cell aggressiveness and radiosensitizing action. These activities could be CAF-1-mediated.
Authors
- Stefania Staibano (ORCID: https://orcid.org/0000-0003-4993-9388)
- Raffaella Belvedere (ORCID: https://orcid.org/0000-0002-5036-7869)
- Antonello Petrella (ORCID: https://orcid.org/0000-0002-6945-5295)
- Francesco Merolla (ORCID: https://orcid.org/0000-0003-0711-6738)
- Roberto Pacelli (ORCID: https://orcid.org/0000-0002-2048-7675)
- Nunzia Novizio
- Mariangela Palazzo (ORCID: https://orcid.org/0009-0007-6625-8353)
- Caterina Oliviero (ORCID: https://orcid.org/0009-0009-5024-8067)
Institutions
- University of Molise (IT)
- University of Salerno (IT)
- Federico II University Hospital (IT)
- University of Naples Federico II (IT)
Publication Details
- Journal
- Pathologica
- Published
- 2024-12-01
- DOI
- https://doi.org/10.32074/1591-951x-1085
- Citations
- 1
- Primary Topic
- Metabolism, Diabetes, and Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.23